SciELO - Scientific Electronic Library Online

 
vol.17 número3Evisceração intestinal transvaginal 8 anos após histerectomia vaginal - uma emergência cirúrgica raraDismenorreia membranosa: uma entidade rara ou esquecida? índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Acta Obstétrica e Ginecológica Portuguesa

versão impressa ISSN 1646-5830

Acta Obstet Ginecol Port vol.17 no.3 Algés set. 2023  Epub 30-Set-2023

 

Issue Image/Imagem do Trimestre

From hematometrocolpos to cervical cancer: when a negative co-test is not reassuring

De hematometrocolpos a cancro do colo do útero: quando o co-teste negativo não é tranquilizador

Marta Gomes de Melo1 
http://orcid.org/0000-0003-2255-7654

Rita Marquez Passarinho1 

Andreia Relva2 

1. Hospital Vila Franca de Xira (HVFX), Vila Franca de Xira, Portugal.

2. Instituto Português de Oncologia de Lisboa Francisco Gentil (IPO-LFG), Lisboa, Portugal.


Abstract

The great majority of malignant lesions of the cervix is associated with human papilloma virus (HPV) positivity and/or altered cytology. We describe a case of cervical cancer with a normal co-test, in which the occurrence of hematometrocolpos in postmenopause led to the correct diagnosis.

Keywords: Cervical cancer; Human papilloma virus; Cytology; Hematocolpos; Hematometra

Resumo

A maioria das lesões malignas cervicais uterinas associa-se a vírus do papiloma humano (HPV) e/ou citologia alterada. Descrevemos um caso de cancro do colo do útero com co-teste normal, cujo estudo diagnóstico foi desencadeado pela presença de hematometrocolpos na pós-menopausa.

Palavras-chave: Cancro do colo do útero; Vírus do papiloma humano; Citologia; Hematocolpos; Hematometra

Introduction

The great majority of malignant cervical lesions is associated with human papilloma virus (HPV) positivity1,2. Nevertheless, 5,5-11% are reported as HPV-negative3. Additionally, false-negative cytology occurs in 27,1% of cases2. When presenting simultaneously, diagnostic delay may occur.

Hematometrocolpos corresponds to blood retention in the uterine cavity and cervix. When presenting in postmenopause, an underlying malignant cause should be investigated4.

Description of the case

A 74-year-old multiparous woman, with chronic hypertension and type 2 diabetes, had had previous excision of the transformation zone (TZ) due to high-grade squamous intraepithelial lesion (HSIL) at 39 years old. She was referred for specialist care at 70 years old following a cytologic HSIL. Colposcopy revealed TZ 3. A new excision of TZ showed cervical intraepithelial neoplasia (CIN) 3 with free margins. Follow-up until the third year was uneventful, with negative exams.

At the third year of follow-up, a flat cervix was observed. A negative co-test was obtained once more. A pelvic ultrasound was performed, discovering hidrometrocolpos (Figure 1), which was corroborated by computed tomography scan. For pain relief, the intracavitary content was drained by cervical permeabilization with a hysterometer and it was hematic.

Figure 1 Transvaginal ultrasound. 

Following uterine bleeding and recidive of hematometrocolpos, a hysteroscopy was performed. A suspicious cervical mass was unveiled and biopsied. Despite an endometrial polypoid image was observed, poor visualization precluded its safe excision. Endocervical biopsies showed CIN 3 and could not unequivocally exclude stromal invasion. Magnetic resonance imaging (MRI) described a cervical neoplasm (Figure 2) and the patient was referred to an Oncology Reference Center.

Figure 2 Abdominal and pelvic MRI, coronal section. 

Endocervical curettage identified HPV-16 and suggested low-grade squamous intraepithelial lesion. The hysteroscopic biopsies were revised in the Oncology Center. One fragment was concordant with squamous cell carcinoma in situ with involved margins. Another one showed stratified squamous epithelium with HSIL and colonization of endocervical glands, with features of stromal invasion.

The MRI was revised and an endometrial lesion with cervical extension was suggested. Positron emission tomography showed high-metabolism lesion involving the inferior third of the endometrium and the cervix. After multidisciplinary discussion, the tumor origin was considered unclear. MRI in the Oncology Center was performed, supporting a cervical origin. No other suspicious lesions were identified. A renal ultrasound was performed due to decreased renal clearance (diabetic and hypertensive-kidney disease), showing no hydronephrosis. Considering the presence of invasive carcinoma and greater dimension of tumor of 4 cm, stage IB2 from 2018 FIGO classification for cervical cancer was assumed.

Considering advanced age and comorbidities impeding surgery and low renal clearance hindering chemotherapy, isolated radiotherapy was decided. The patient was submitted to intensity-modulated radiation therapy (45Gy/25 fractions) followed by high-dose-rate intrauterine brachytherapy (24Gy/3 fractions). She presents no clinical nor imagiologic signs of recidive at one-year follow-up.

Conclusions

The clinical presentation of cervical cancer may be atypical, with negative co-test and presentation of hematometrocolpos. Advanced age and inherent limitations of HPV tests may contribute to its false-negative results3. Differential diagnosis with endometrial neoplasia may be difficult. A low threshold of suspicion should be kept when facing hematometrocolpos in a postmenopausal woman4.

Author’s contribution

Marta Gomes de Melo was responsible for the conceptualization, clinical care of the patient - diagnosis, and writing - original draft, review and editing. Rita Marquez Passarinho was responsible for clinical care of the patient - diagnosis, and writing - review and editing. Andreia Relva was responsible for clinical care of the patient including diagnosis, treatment and follow-up and writing - review and editing.

Conflicts of interest

The authors declare they have no conflicts of interest.

Informed consent

Written consent from the patient was obtained.

References

1. Palefski J. Human papillomavirus infections: epidemiology and disease associations. UpToDate. 2022. [ Links ]

2. Castillo M, Astudillo A, Clavero O, Velasco J, Ibáñez R, Sanjosé S. Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening. PLOS ONE. 2016;11(8):e0161403. [ Links ]

3. Xing B, Guo J, Sheng Y, Wu G, Zhao Y. Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review. Frontiers in Oncology. 2021;10. [ Links ]

4. Jawaher A, Kareemah A, Musab A, Nora A, Afaf F. Five liters of hematometra in postmenopausal woman case of advance stage of endometrial cancer. JOJ Case Stud. 2019;10(1). [ Links ]

Received: December 31, 2022; Accepted: May 03, 2023

Correspondence to Marta Filipa Gomes de Melo E-mail: martafilipamelo@gmail.com

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License